Complete Health Care Guide

Posts Tagged ‘asthma treatment’

Article by Juliet Cohen

Asthma Care Tips

1.Leukotriene modifiers (montelukast, zafirlukast, and zileuton), which used either alone to treat mild persistent asthma.

2nd. Cromolyn and nedocromil which is used to treat mild persistent asthma.

3. Theophylline, used either alone to treat mild persistent asthma or together with inhaled corticosteroids in treating persistent asthma is.

4. Long-term use of corticosteroids can have many side effects including fat redistribution, increased appetite, blood glucose problems and weight loss.

5. Deposition of steroids in the mouth can cause hoarseness or oral thrush (due to decreased immunity).

6. Leukotriene modifiers (montelukast, zafirlukast, pranlukast, and zileuton).

7. Mast cell stabilizers (cromoglicate (cromolyn) and nedocromil).

8. Antimuscarinics / anticholinergic (ipratropium, oxitropium, and tiotropium), which has the effect of mixed relief and prevention.

9. Methylxanthines (theophylline and aminophylline), which are sometimes considered if sufficient control cannot be achieved with inhaled glucocorticoid and long-acting ß-agonists alone.

10. Antihistamines often used to treat allergic symptoms that may underlie inflammation.

11. Methotrexate is sometimes used in some hard-to-treat patients.

12. Guaifenesin, an expectorant available over the counter, may have little impact in managing the thick bronchial mucus.

Asthma is a common disease in which airways in the lungs become inflamed and then narrow when muscles within the airway walls contract. Conventional therapy using two types of short-term reliever medication and long-term controller. Temporary relief as the name suggests, treating the symptoms and eliminate them, providing short-term assistance, during an attack intended to suppress the controller inflammation in the airways. But this therapy may not be effective in treating conditions that are severe or persistent.

Is the treatment of bronchial asthma thermoplasty new potential undergoing clinical testing. Developed by a medical device company called Asthma., this procedure has the potential to provide assistance to patients with asthma who did not respond to conventional treatment. A clinical trial conducted in sixteen adults with mild to moderate asthma who did not respond to current asthma treatment. The results of this study is encouraging as 75 percent of participants reported that the new treatment is allowed to function better in daily activities and reduce the peak expiratory flow readings. Read the rest of this entry »